(Q30978537)

27 June 2017

title

Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching (English)

1 reference

27 June 2017

main subject

angiogenesis inhibitor

1 reference

Pascal Furet

1

1 reference

27 June 2017

Guido Bold

2

1 reference

27 June 2017

Francesco Hofmann

3

1 reference

27 June 2017

Paul Manley

4

1 reference

27 June 2017

Thomas Meyer

5

1 reference

27 June 2017

Karl-Heinz Altmann

6

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

27 June 2017

published in

1 reference

27 June 2017

volume

13

1 reference

27 June 2017

issue

18

1 reference

27 June 2017

page(s)

2967-2971

1 reference

Tumor angiogenesis as a therapeutic target

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Inhibition of tumor angiogenesis by synthetic receptor tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Anthranilic acid amides: a novel class of antiangiogenic VEGF receptor kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Strategies toward the design of novel and selective protein tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Structure-based design and protein X-ray analysis of a protein kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

A rapid method for the computation, comparison and display of molecular volumes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

MOPAC: a semiempirical molecular orbital program

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900626-7

7 January 2021

10.1016/S0960-894X(03)00626-7

Identifiers

DOI

1 reference

27 June 2017

1 reference